Corrigendum to: Purity, adulteration and price of drugs bought on-line versus off-line in the Netherlands: On-line and off-line drug quality and price (Addiction, (2017), 112, 4, (640-648), 10.1111/add.13720);Purity, adulteration and price of drugs bought on-line versus off-line in the Netherlands

Addiction

Volumn 112, Issue 4, 2017, Pages 640-648

  van der Gouwe, Daan ^a   Brunt, Tibor M ^a   van Laar, Margriet ^a   van der Pol, Peggy ^a  

^a NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

Author keywords

Adulteration; cryptomarkets; darknet; dosage; drug markets; price; purity; quality; webshops

Indexed keywords

2-(3-METHOXYPHENYL)-2-(ETHYLAMINO)CYCLOHEXANONE; 2-(4-BROMO-2,5-DIMETHOXYPHENYL)ETHYLAMINE; 4-FLUOROAMPHETAMINE; 5-(2-AMINOPROPYL)BENZOFURAN; AMPHETAMINE; AMPHETAMINE DERIVATIVE; BENZOFURAN DERIVATIVE; CENTRAL STIMULANT AGENT; COCAINE; CYCLOHEXANONE DERIVATIVE; CYCLOHEXYLAMINE DERIVATIVE; HOMOVERATRYLAMINE; LYSERGIDE; MIDOMAFETAMINE; PROPYLAMINE; PSYCHEDELIC AGENT; STREET DRUG;

ANALOGS AND DERIVATIVES; CHEMISTRY; DRUG CONTAMINATION; DRUG COST; DRUG TRAFFIC; ECONOMICS; HUMAN; INTERNET; NETHERLANDS;

AMPHETAMINE; AMPHETAMINES; BENZOFURANS; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; CYCLOHEXANONES; CYCLOHEXYLAMINES; DIMETHOXYPHENYLETHYLAMINE; DRUG CONTAMINATION; DRUG COSTS; DRUG TRAFFICKING; HALLUCINOGENS; HUMANS; INTERNET; LYSERGIC ACID DIETHYLAMIDE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NETHERLANDS; PROPYLAMINES; STREET DRUGS;

EID: 85011635967     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.13933     Document Type: Erratum

References (38)

1. European Monitoring Centre for Drugs and Drug Addiction. Online Sales of New Psychoactive Substances/‘Legal Highs’: Summary of Results from the 2011 Multilingual Snapshots [Briefing Paper]. Lisbon: EMCDDA; 2011, pp. 3–7.
2. Barratt M. J. Silk Road: eBay for drugs. Addiction 2012; 107: 683.
3. Van Hout M. C., Bingham T. Surfing the Silk Road: a study of users’ experiences. Int J Drug Policy 2013; 24: 524–529.
4. Van Hout M. C., Bingham T. Silk Road, the virtual drug marketplace: a single case study of user experiences. Int J Drug Policy 2013; 24: 385–391.
5. Van Buskirk J., Roxburgh A., Bruno R., Naicker S., Lenton S., Sutherland R. et al. Characterising dark net marketplace purchasers in a sample of regular psychostimulant users. Int J Drug Policy 2016; 35: 32–37.
6. Christin N. Traveling the Silk Road: a measurement analysis of a large anonymous online marketplace. Proceedings of the 22nd international conference on World Wide Web. Geneva, Switzerland: International World Wide Web Conferences Steering Committee; 2013.
7. Kruithof K., Aldridge J., Decary-Hetu D., Sim M., Dujso E., Hoorens S. Internet-facilitated Drugs Trade. Santa Monica, CA/Cambridge, UK: RAND Corporation; 2016, pp. 21–32.
8. Buxton J., Bingham T. The Rise and Challenge of Dark Net Drug Markets. Policy Brief 7 (2015). Swansea: University of Swansea; 2015, pp. 1–5.
9. Winstock A. R. Global Drug Survey. 2016-10-03. Available at: http://www.globaldrugsurvey.com (accessed 4 December 2016) (Archived at http://www.webcitation.org/6kyfAscMz).
10. Barratt M. J., Ferris J. A., Winstock A. R. Use of Silk Road, the online drug market-place, in the United Kingdom, Australia and the United States. Addiction 2014; 109: 774–783.
11. Martin J. Lost on the Silk Road: online drug distribution and the ‘cryptomarket’. Criminol Crim Just 2014; 14: 351–367.
12. Caudevilla F., Ventura M., Fornis I., Barratt M. J., Vidal C., Lladanosa C. G. et al. Results of an international drug testing service for cryptomarket users. Int J Drug Policy 2016; 35: 38–41.
13. Winstock A. R. Global Drug Survey. 2016-10-03. Available at: http://www.globaldrugsurvey.com (accessed 8 May 2016) (Archived at http://www.webcitation.org/6kyfAscMz).
14. Mountenay J., Oteo A., Griffiths P. The Internet and Drug Markets (Insights 21). European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): Luxembourg; 2016, pp. 13–17; 69–75.
15. Martin J. Drugs on the Dark Net: How Cryptomarkets are Transforming the Global Trade in Illicit Drugs. Basingstoke: Palgrave Macmillan; 2014, pp. 36–41.
16. Soska K., Christin N. Measuring the longitudinal evolution of the online anonymous marketplace ecosystem. Washington, DC: 24th USENIX Security Symposium (USENIX Security 15); 12–14 August 2015.
17. Aldridge J., Décary-Hety D. Not an ‘Ebay for Drugs: The Cryptomarket Silk Road as a Paradigm Shifting Criminal Innovation. Manchester: University of Manchester; 2014, pp. 2–20.
18. Orsolini L., Francesconi G., Papanti D., Giorgetti A., Schifano F. Profiling online recreational/prescription drugs’ customers and overview of drug vending virtual marketplaces. Hum Psychopharmacol 2015; 30: 302–318.
19. Bancroft A., Scott R. P. Concepts of illicit drug quality among darknet market users: Purity, embodied experience, craft and chemical knowledge. Int J Drug Policy 2016; 35: 42–49.
20. Vogels N., Brunt T. M., Rigter S., van Dijk P., Vervaeke H., Niesink R. J. Content of ecstasy in the Netherlands: 1993–2008. Addiction 2009; 104: 2057–2066.
21. Brunt T. M., Niesink R. J. The Drug Information and Monitoring System (DIMS) in the Netherlands: implementation, results, and international comparison. Drug Test Anal 2011; 3: 621–634.
22. Brunt T. M., Koeter M. W., Niesink R. J., van den Brink W. Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users. Psychopharmacology (Berl) 2012; 220: 751–762.
23. Brunt T. M., Nagy C., Bucheli A., Martins D., Ugarte M., Beduwe C. et al. Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project. Drug Test Anal 2016; DOI: 10.1002/dta.1954.
24. Benschop A., Rabes M., Korf D. J., Eggerth H. Pill Testing, Ecstasy and Prevention: A Scientific Evaluation in Three European Cities. Amsterdam: Rozenberg Publishers; 2002, pp. 29–38.
25. Korf D. J., Benschop A., Brunt T. M., Dallas M. Pillen testen in Nederland: een onderzoek naar versterking van de monitor uitgaansdrugs [Pills Tests in the Netherlands: a Study to Strengthen the Monitoring of Party Drugs]. Amsterdam: Rozenberg Publishers; 2003, pp. 39–45.
26. Brunt T. M., Rigter S., Hoek J., Vogels N., van Dijk P., Niesink R. J. An analysis of cocaine powder in the Netherlands: content and health hazards due to adulterants. Addiction 2009; 104: 798–805.
27. van Laar M. W., van Ooyen-Houben M. M. J., Cruts A. A. N., Meijer R. F., Croes E. A., Ketelaars A. P. M. National Drugs Monitor. Annual Report 2015. Trimbos-instituut: Utrecht; 2015, p. 36.
28. Buchanan J. A., Vogel J. A., Eberhardt A. M. Levamisole-induced occlusive necrotizing vasculitis of the ears after use of cocaine contaminated with levamisole. J Med Toxicol 2011; 7: 83–84.
29. Gaertner E. M., Switlyk S. A. Dermatologic complications from levamisole-contaminated cocaine: a case report and review of the literature. Cutis 2014; 93: 102–106.
30. Vevelstad M., Oiestad E. L., Middelkoop G., Hasvold I., Lilleng P., Delaveris G. J. et al. The PMMA epidemic in Norway: comparison of fatal and non-fatal intoxications. Forensic Sci Int 2012; 219: 151–157.
31. Van der Gouwe D. Jaarbericht 2014. Drugs Informatie en Monitoring Systeem (DIMS). Utrecht: Trimbos-instituut; 2015.
32. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) European Drug Report 2015. Trends and Developments. Luxembourg: EMCDDA, 2016, pp. 27–30.
33. Van der Gouwe D. Annual Report 2015. Drugs Information and Monitoring System (DIMS). Utrecht: Trimbos-instituut; 2016.
34. Belackova V., Maalste N., Zabransky T., Grund J. P. Should I buy or should I grow? How drug policy institutions and drug market transaction costs shape the decision to self-supply with cannabis in the Netherlands and the Czech Republic. Int J Drug Policy 2015; 26: 296–310.
35. European Monitoring Centre for Drugs and Drug Addiction (EMVDDA). Europol European Drug Markets Report. In-depth Analysis. Lisbon/The Hague: EMCDDA; 2016, p. 116.
36. Van Buskirk J., Naicker S., Roxburgh A., Bruno R., Burns L. Who sells what? Country specific differences in substance availability on the Agora cryptomarket. Int J Drug Policy 2016; 35: 16–23.
37. Aldridge J., Decary-Hetu D. Hidden wholesale: the drug diffusing capacity of online drug cryptomarkets. Int J Drug Policy 2016; 35: 7–15.
38. Barratt M. J., Lenton S., Maddox A., Allen M. What if you live on top of a bakery and you like cakes? Drug use and harm trajectories before, during and after the emergence of Silk Road. Int J Drug Policy 2016; 35: 50–57.